V019-6103 Screening compound: N-benzyl-N-{[4-(2-methoxyphenyl)-1-[(5-methylfuran-2-yl)methyl]pyrrolidin-3-yl]methyl}-2-methylpropanamide

V019-6103 Screening compound: N-benzyl-N-{[4-(2-methoxyphenyl)-1-[(5-methylfuran-2-yl)methyl]pyrrolidin-3-yl]methyl}-2-methylpropanamide
V019-6103 Screening compound: N-benzyl-N-{[4-(2-methoxyphenyl)-1-[(5-methylfuran-2-yl)methyl]pyrrolidin-3-yl]methyl}-2-methylpropanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V019-6103
N-benzyl-N-{[4-(2-methoxyphenyl)-1-[(5-methylfuran-2-yl)methyl]pyrrolidin-3-yl]methyl}-2-methylpropanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V019-6103

Molecular Formula

C29H36N2O3 (C29 H36 N2 O3)

Compound Name

N-benzyl-N-{[4-(2-methoxyphenyl)-1-[(5-methylfuran-2-yl)methyl]pyrrolidin-3-yl]methyl}-2-methylpropanamide

IUPAC name

N-benzyl-N-{[4-(2-methoxyphenyl)-1-[(5-methylfuran-2-yl)methyl]pyrrolidin-3-yl]methyl}-2-methylpropanamide

SMILES

CC(C)C(N(CC(CN(Cc1ccc(C)o1)C1)C1c(cccc1)c1OC)Cc1ccccc1)=O

InChI

InChI=1S/C29H36N2O3/c1-21(2)29(32)31(16-23-10-6-5-7-11-23)18-24-17-30(19-25-15-14-22(3)34-25)20-27(24)26-12-8-9-13-28(26)33-4/h5-15,21,24,27H,16-20H2,1-4H3

InChI Key

UUULAZICRIRMQA-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19922508

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

460.62

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

5.440

Distribution Coefficient, logD

2.032

Water Solubility, LogSw

-5.31

Polar Surface Area

35.037

Acid Dissociation Constant (pKa)

22.33

Base Dissociation Constant (pKb)

10.81

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

41.40

V019-6103 in Drug Discovery

Included in Screening Libraries

Macl-GPIb alpha Interaction Library (22969 compounds)

Inhibitors of beta-Catenin Signaling (7445 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Hemic and lymphatic
  • Cardiovascular

References: we are preparing a list of scientific research reports with V019-6103 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V019-6103?
Check Price and Availability of V019-6103, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V019-6103 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V019-6103
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V019-6103
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V019-6103 available by request